Literature DB >> 11473833

Designer dendritic cells for tolerance induction: guided not misguided missiles.

H Hackstein1, A E Morelli, A W Thomson.   

Abstract

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that play crucial roles as initiators and modulators of adaptive immune responses. Although DC-based vaccines have been utilized successfully to generate cytolytic T-cell activity against tumor antigens (Ags), evidence has accumulated that DCs also have potent capabilities to tolerize T cells in an Ag-specific manner. DCs cultured in the laboratory can suppress auto- or alloimmunity. Current and prospective strategies to promote this inherent tolerogenic potential of DCs might prove to be important for the therapy of transplant rejection and autoimmune diseases.

Entities:  

Mesh:

Year:  2001        PMID: 11473833     DOI: 10.1016/s1471-4906(01)01959-7

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  13 in total

Review 1.  Intravenous immunoglobulin and dendritic cells.

Authors:  Namita Misra; Jagadeesh Bayry; Jagadeesh Bayary; Sooryasarathi Dasgupta; Amal Ephrem; Jean-Paul Duong Van Huyen; Sandrine Delignat; Gazzala Hassan; Giuseppina Caligiuri; Antonino Nicoletti; Sebastien Lacroix-Desmazes; Michel D Kazatchkine; Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

2.  Regulatory cytokine production stimulated by DNA vaccination against an altered form of glutamic acid decarboxylase 65 in nonobese diabetic mice.

Authors:  Yelena Glinka; Renée De Pooter; France Croze; Gérald J Prud'homme
Journal:  J Mol Med (Berl)       Date:  2003-02-11       Impact factor: 4.599

3.  Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma.

Authors:  Ya-Hui Chuang; Jau-Ling Suen; Bor-Luen Chiang
Journal:  J Mol Med (Berl)       Date:  2006-03-25       Impact factor: 4.599

Review 4.  Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.

Authors:  Christian Schütz; Mathias Oelke; Jonathan P Schneck; Andreas Mackensen; Martin Fleck
Journal:  Immunotherapy       Date:  2010-07       Impact factor: 4.196

5.  TGF-beta1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression.

Authors:  Hai-bo Mou; Mao-fang Lin; Hong Cen; Jing Yu; Xiao-jian Meng
Journal:  J Zhejiang Univ Sci       Date:  2004-10

6.  Human Chorionic Villous Mesenchymal Stem Cells Modify the Functions of Human Dendritic Cells, and Induce an Anti-Inflammatory Phenotype in CD1+ Dendritic Cells.

Authors:  F M Abomaray; M A Al Jumah; B Kalionis; A S AlAskar; S Al Harthy; D Jawdat; A Al Khaldi; A Alkushi; B A Knawy; M H Abumaree
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

7.  Induction of peripheral tolerance by local delivery of dendritic cell progenitors to cardiac allografts in a murine heterotopic heart transplantation model.

Authors:  Hiroharu Hikawa; Michael T Lotze; Warren D Rosenblum
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-08

8.  Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?

Authors:  Slobodan Culina; Christian Boitard; Roberto Mallone
Journal:  Clin Dev Immunol       Date:  2011-05-14

Review 9.  Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

Authors:  Brett Phillips; Massimo Trucco; Nick Giannoukakis
Journal:  Clin Dev Immunol       Date:  2011-07-18

10.  Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus.

Authors:  JiChu Li; JooHung Park; Deborah Foss; Irving Goldschneider
Journal:  J Exp Med       Date:  2009-03-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.